Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,752.18
+0.30%
DAX
26,237.10
-0.39%
CAC 40
8,542.80
-0.43%
STOXX 50
6,500.51
-0.46%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 02 December 2020 10:39 am

‘No corners have been cut’: UK’s top scientists ward off anti-vaxxers with vaccine rollout plan

By: Poppy Wood

Add as a preferred source on Google

The Pfizer/Biontech vaccine has been approved following “an extremely thorough and scientifically rigorous review” of safety evidence, the UK’s top scientists said this morning as they swooped to ward off anti-vaxxer rhetoric.

“No corners have been cut — none at all,” said Dr June Raine, chief executive of the Medical and Healthcare products Regulatory Agency (MHRA), which this morning approved the Pfizer/Biontech vaccine for use in the UK.

Vaccines usually take around a decade from start to finish before they hit the shelves, whereas Pfizer’s will start wide-scale rollout within a year of being first developed.

“Our expert scientists and clinicians have worked round the clock, carefully and methodically poring over tables, analyses and graphs on hundreds of thousands of pages of data,” Raine added. “The safety of the public will always come first”.

Wide-scale vaccination will start in the next few days as the UK this morning became the first country in the world to approve a vaccine.

Military personnel have been called in to transform around 10 sites into vaccine hubs within a fortnight, including the Nightingale hospital at London’s Excel centre. 

Professor Wei Shen Lim, chair of the Joint Committee on Vaccines and Immunisation (JCVI), this morning set out the NHS priority list for vaccination.

Lim said the JCVI’s current recommendations are that vaccination should go first to those most at risk and to health professionals, with “age by far the single biggest risk factor”.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Care home residents will likely be first in line for vaccinations, followed by those over 80-years-old and frontline health and social care staff.

Source: gov.uk

Health secretary Matt Hancock said the approval of the Pfizer vaccine means the UK will return to normality by the spring. 

Hancock vouched to take the vaccine live on air to prove it was safe for public use, as the government prepares to armour the UK against anti-vaxxer disinformation.

“If that can help anybody else, persuade anybody else, that they should take the vaccine then I think it’s worth it,” he said.

It comes after Pfizer’s announcement this morning ignited conspiracy theories across social media sites.

“Thalidomide” was trending on Twitter just hours after the MHRA announced it had approved the jab from the US drugs firm. 

The government last week said it has mobilised the army to utilise an elite “information warfare” unit to counter online propaganda against vaccines.

Leaked documents revealed that its soldiers are already monitoring cyberspace for Covid-19 content and analysing how British citizens are being targeted online.

Read more

Luton Airport expansion set for take-off after environmental challenge dismissed

Luton Airport aerial view with planes, runways, and terminal buildings, highlighting busy travel hub operations

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Vaccine

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Monzo chair makes early exit after boardroom rift

  • Aldi boss wades into supermarket ‘price-gouging’ row

  • New Premier League rules could see £11bn invested into new stadiums

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Luton Airport expansion set for take-off after environmental challenge dismissed

    Transport & Infrastructure
    Luton Airport aerial view with planes, runways, and terminal buildings, highlighting busy travel hub operations
  • Gatwick expansion green-lit as court throws out activists’ appeal

    Transport & Infrastructure
    20m passengers have flown through Gatwick this year
  • UK’s AI watchdog flags new OpenAI and Anthropic cyber alarms

    AI
    Smartphone displaying the Claude by Anthropic AI assistant app, showing the app icon and interface.
  • Cleansed is still the most harrowing play you’ll ever see

    Life&Style
    A man and woman in an intimate embrace, surrounded by a field of orange and yellow flowers on a dark stage
  • Exclusive: Big Four giant KPMG to cut more jobs

    Big Four
    KPMG office building exterior with company logo under clear blue sky, representing global professional services firm
  • Nobel Peace Prize maker’s UK arm seeks administrator

    Business
    Close-up of a golden Nobel Prize medal featuring Alfred Nobels profile on a dark, textured background.
  • AI gold rush leaves accountancy firms exposed to costly cyberattacks

    AI
    Two tablets displaying code and a cyber warning symbol, with blurry blue and pink background numbers
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook